SureNano Science
Tracked across 1 events · 7 articles · First seen May 12, 2026 · Last active May 14, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: SureNano Science is advancing its next-generation GLP-1 platform through its subsidiary GlucaPharm Inc., developing GEP-44 for obesity and metabolic disorders, which could significantly boost its market position.
May 12, 2026 · 7 articles
ERGEN INTELLIGENCE
Track SureNano Science live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard